• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CHADS(2)和CHA(2)DS(2)VASc评分作为二级预防中的心源性栓塞源预测指标。

CHADS(2) and CHA(2)DS(2)VASc scores as predictors of cardioembolic sources in secondary stroke prevention.

作者信息

Sá Tiago, Sargento-Freitas João, Pinheiro Vítor, Martins Rui, Teixeira Rogério, Silva Fernando, Mendonça Nuno, Cordeiro Gustavo, Gonçalves Lino, Providência Luís A, Freire-Gonçalves António, Cunha Luís

机构信息

Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal.

出版信息

Rev Port Cardiol. 2013 May;32(5):373-8. doi: 10.1016/j.repc.2012.09.007. Epub 2013 Apr 6.

DOI:10.1016/j.repc.2012.09.007
PMID:23566635
Abstract

INTRODUCTION AND OBJECTIVES

Cardioembolism is one of the most common causes of ischemic stroke, with an estimated prevalence of 20-30%, and correct diagnosis is essential given the therapeutic implications. Although stroke risk scores (CHADS2 and more recently CHA2DS2-VASc) have been validated in heterogeneous populations of patients with atrial fibrillation, their accuracy has not been ascertained for secondary stroke prevention. We set out to assess the sensitivity and specificity of the CHADS2 and CHA2DS2-VASc stroke risk scores as predictors of cardioembolic sources, documented by transesophageal echocardiography (TEE) in a population with ischemic stroke.

METHODS

The CHADS2 and CHA2DS2-VASc scores were applied to all patients admitted to the stroke unit/neurology ward of a Portuguese tertiary hospital with atrial fibrillation (diagnosed previously or during or after admission) who underwent TEE between January and August 2011. The presence of a cardioembolic source was defined as the observation by TEE of spontaneous echo contrast in the left atrium and atrial appendage or thrombi in the left cardiac chambers.

RESULTS

We studied 94 patients, 66.0% male, mean age 64.4 years (standard deviation 14.2). A cardioembolic source was detected in 20 patients. ROC curve analysis identified as predictors of cardioembolic source CHADS2 score ≥4 (sensitivity of 75.0%, specificity of 66.0%, p=0.014) and CHA2DS2-VASc score ≥5 (sensitivity of 83.3%, specificity of 58.0%, p=0.009).

CONCLUSIONS

Both scores showed acceptable sensitivity as predictors of embolic risk in the context of secondary prevention of cardioembolic stroke. The CHA2DS2-VASc score has higher sensitivity than CHADS2 but lower specificity.

摘要

引言与目的

心源性栓塞是缺血性卒中最常见的病因之一,估计患病率为20%-30%,鉴于其治疗意义,正确诊断至关重要。尽管卒中风险评分(CHADS2以及最近的CHA2DS2-VASc)已在心房颤动患者的异质性群体中得到验证,但其在二级卒中预防中的准确性尚未确定。我们旨在评估CHADS2和CHA2DS2-VASc卒中风险评分作为心源性栓塞来源预测指标的敏感性和特异性,这些来源通过经食管超声心动图(TEE)在缺血性卒中患者群体中得以记录。

方法

CHADS2和CHA2DS2-VASc评分应用于2011年1月至8月期间入住葡萄牙一家三级医院卒中单元/神经内科病房且患有心房颤动(入院前、入院期间或入院后诊断)并接受TEE检查的所有患者。心源性栓塞来源的存在定义为TEE观察到左心房和心耳内的自发回声增强或左心腔内的血栓。

结果

我们研究了94例患者,男性占66.0%,平均年龄64.4岁(标准差14.2)。20例患者检测到心源性栓塞来源。ROC曲线分析确定CHADS2评分≥4(敏感性75.0%,特异性66.0%,p=0.014)和CHA2DS2-VASc评分≥5(敏感性83.3%,特异性58.0%,p=0.009)为心源性栓塞来源的预测指标。

结论

在预防心源性栓塞性卒中的二级预防中,这两种评分作为栓塞风险预测指标均显示出可接受的敏感性。CHA2DS2-VASc评分比CHADS2评分具有更高的敏感性,但特异性较低。

相似文献

1
CHADS(2) and CHA(2)DS(2)VASc scores as predictors of cardioembolic sources in secondary stroke prevention.CHADS(2)和CHA(2)DS(2)VASc评分作为二级预防中的心源性栓塞源预测指标。
Rev Port Cardiol. 2013 May;32(5):373-8. doi: 10.1016/j.repc.2012.09.007. Epub 2013 Apr 6.
2
Usefulness of transesophageal echocardiography to confirm clinical utility of CHA2DS2-VASc and CHADS2 scores in atrial flutter.经食管超声心动图在确认 CHA2DS2-VASc 和 CHADS2 评分在心房扑动中的临床实用性中的作用。
Am J Cardiol. 2012 Feb 15;109(4):550-5. doi: 10.1016/j.amjcard.2011.10.007. Epub 2011 Nov 29.
3
Correlation of CHADS2 and CHA2DS2-VASc scores with transesophageal echocardiography risk factors for thromboembolism in a multiethnic United States population with nonvalvular atrial fibrillation.多民族美国人群中非瓣膜性心房颤动患者 CHADS2 和 CHA2DS2-VASc 评分与经食管超声心动图血栓栓塞危险因素的相关性。
J Am Soc Echocardiogr. 2013 Feb;26(2):175-84. doi: 10.1016/j.echo.2012.11.002. Epub 2012 Dec 17.
4
The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.在接受抗凝治疗的房颤患者中,HAS-BLED 评分对大出血的预测准确性优于 CHADS2 或 CHA2DS2-VASc 评分。
J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18.
5
Correlation of Left Atrial Appendage Ejection Velocities with the CHADS2 and CHA2DS2-VASc Scores.左心耳射血速度与CHADS2及CHA2DS2-VASc评分的相关性
Echocardiography. 2016 Aug;33(8):1195-201. doi: 10.1111/echo.13228. Epub 2016 Apr 5.
6
Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation.房颤急性缺血性卒中患者入院前CHADS2、CHA2DS2-VASc及R2CHADS2评分与严重程度及功能转归的关系
J Stroke Cerebrovasc Dis. 2015 Jul;24(7):1629-35. doi: 10.1016/j.jstrokecerebrovasdis.2015.03.036. Epub 2015 Apr 20.
7
Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?用于心房颤动中风风险分层的CHADS2和CHA2DS2-VASc评分比较:亚洲人应使用哪种评分系统?
Heart Rhythm. 2016 Jan;13(1):46-53. doi: 10.1016/j.hrthm.2015.08.017. Epub 2015 Aug 12.
8
The CHA(2)DS(2)-VASc score reflects clinical outcomes in nonvalvular atrial fibrillation patients with an initial cardioembolic stroke.CHA(2)DS(2)-VASc 评分反映了伴有首发心源性脑卒的非瓣膜性心房颤动患者的临床结局。
J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e343-6. doi: 10.1016/j.jstrokecerebrovasdis.2013.02.018. Epub 2013 Mar 20.
9
Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.中风前 CHADS2 和 CHA2DS2-VASc 评分可用于分层伴有和不伴有心房颤动的患者三个月结局。
Cerebrovasc Dis. 2013;36(4):273-80. doi: 10.1159/000353670. Epub 2013 Oct 16.
10
Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.肾功能障碍、卒中风险评分(CHADS2、CHA2DS2-VASc 和 R2CHADS2)与心房颤动导管消融术后血栓栓塞事件风险:莱比锡心脏中心房颤消融登记研究。
Circ Arrhythm Electrophysiol. 2013 Oct;6(5):868-74. doi: 10.1161/CIRCEP.113.000869. Epub 2013 Sep 18.

引用本文的文献

1
Can we manage prophylactic therapy in COVID-19 patients to prevent severe illness complications?我们能否对新冠肺炎患者进行预防性治疗以预防严重疾病并发症?
J Vasc Bras. 2020 May 20;19:e20200057. doi: 10.1590/1677-5449.200057.
2
The predictive value of the CHA2DS2-VASc score in patients with mechanical mitral valve thrombosis.机械二尖瓣血栓形成患者 CHA2DS2-VASc 评分的预测价值。
J Thromb Thrombolysis. 2018 May;45(4):571-577. doi: 10.1007/s11239-018-1640-3.
3
Left Atrial Strain Predicts Pro-Thrombotic State in Patients with Non-Valvular Atrial Fibrillation.
左心房应变预测非瓣膜性心房颤动患者的血栓前状态。
J Atr Fibrillation. 2017 Dec 31;10(4):1641. doi: 10.4022/jafib.1641. eCollection 2017 Dec.
4
The CHA2DS2-VASc score as a predictor of left atrial thrombus in patients with non-valvular atrial fibrillation.CHA2DS2-VASc评分作为非瓣膜性心房颤动患者左心房血栓形成的预测指标。
Med Princ Pract. 2014;23(3):234-8. doi: 10.1159/000361028. Epub 2014 Apr 16.